US Pharma Biz Indivior Cancels London Listing
Pharmaceuticals company Indivior PLC said on Friday that its admission to trading on the London Stock Exchange has been canceled, but that it will retain its U.S. listing, which it believes...To view the full article, register now.
Already a subscriber? Click here to view full article